DFA
AGN

Delta Financial Advisors’s Allergan plc AGN Stock Holding History

Delta Financial Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,205
Closed -$213K – 103
2020
Q1 		$213K Sell
1,205
-1,845
-60% -$347K 0.15% 96
2019
Q4 		$583K Sell
3,050
-40
-1% -$7.22K 0.23% 90
2019
Q3 		$520K Hold
3,090
– – 0.21% 94
2019
Q2 		$517K Buy
+3,090
New +$428K 0.21% 92

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Delta Financial Advisors's AGN Position: Q2 2020 in Review

Delta Financial Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,205 shares — an estimated $213K sold.

Delta Financial Advisors first reported a position in AGN in Q2 2019 and held it in 4 quarters. The position peaked at $583K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Delta Financial Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Delta Financial Advisors sold 1,205 Allergan plc shares in Q2 2020, an estimated $213K.
  • Delta Financial Advisors first reported a position in Allergan plc in Q2 2019 and held it in 4 quarters.
  • Delta Financial Advisors's Allergan plc position peaked at $583K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Delta Financial Advisors's 13F filing for Q2 2020, filed 4 Aug 2020.